BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 33761889)

  • 1. Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer.
    Malik V; Kalakoti Y; Sundar D
    BMC Genomics; 2021 Mar; 22(1):214. PubMed ID: 33761889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Super.FELT: supervised feature extraction learning using triplet loss for drug response prediction with multi-omics data.
    Park S; Soh J; Lee H
    BMC Bioinformatics; 2021 May; 22(1):269. PubMed ID: 34034645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis.
    Tong L; Mitchel J; Chatlin K; Wang MD
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):225. PubMed ID: 32933515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating multi-omics data through deep learning for accurate cancer prognosis prediction.
    Chai H; Zhou X; Zhang Z; Rao J; Zhao H; Yang Y
    Comput Biol Med; 2021 Jul; 134():104481. PubMed ID: 33989895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A deep learning approach based on multi-omics data integration to construct a risk stratification prediction model for skin cutaneous melanoma.
    Li W; Huang Q; Peng Y; Pan S; Hu M; Wang P; He Y
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15923-15938. PubMed ID: 37673824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data.
    Takahashi S; Asada K; Takasawa K; Shimoyama R; Sakai A; Bolatkan A; Shinkai N; Kobayashi K; Komatsu M; Kaneko S; Sese J; Hamamoto R
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33086649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capturing the latent space of an Autoencoder for multi-omics integration and cancer subtyping.
    Madhumita ; Paul S
    Comput Biol Med; 2022 Sep; 148():105832. PubMed ID: 35834966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. kESVR: An Ensemble Model for Drug Response Prediction in Precision Medicine Using Cancer Cell Lines Gene Expression.
    Majumdar A; Liu Y; Lu Y; Wu S; Cheng L
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
    Liu C; Wang X; Genchev GZ; Lu H
    Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOLI: multi-omics late integration with deep neural networks for drug response prediction.
    Sharifi-Noghabi H; Zolotareva O; Collins CC; Ester M
    Bioinformatics; 2019 Jul; 35(14):i501-i509. PubMed ID: 31510700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
    Huang S; Hu P; Lakowski TM
    BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer.
    Tong L; Wu H; Wang MD
    Methods; 2021 May; 189():74-85. PubMed ID: 32763377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A denoised multi-omics integration framework for cancer subtype classification and survival prediction.
    Pang J; Liang B; Ding R; Yan Q; Chen R; Xu J
    Brief Bioinform; 2023 Sep; 24(5):. PubMed ID: 37594302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topological integration of RPPA proteomic data with multi-omics data for survival prediction in breast cancer via pathway activity inference.
    Kim TR; Jeong HH; Sohn KA
    BMC Med Genomics; 2019 Jul; 12(Suppl 5):94. PubMed ID: 31296204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving prediction performance of colon cancer prognosis based on the integration of clinical and multi-omics data.
    Tong D; Tian Y; Zhou T; Ye Q; Li J; Ding K; Li J
    BMC Med Inform Decis Mak; 2020 Feb; 20(1):22. PubMed ID: 32033604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data.
    Lin Y; Zhang W; Cao H; Li G; Du W
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32759821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of drug sensitivity based on multi-omics data using deep learning and similarity network fusion approaches.
    Liu XY; Mei XY
    Front Bioeng Biotechnol; 2023; 11():1156372. PubMed ID: 37139048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DeepProg: an ensemble of deep-learning and machine-learning models for prognosis prediction using multi-omics data.
    Poirion OB; Jing Z; Chaudhary K; Huang S; Garmire LX
    Genome Med; 2021 Jul; 13(1):112. PubMed ID: 34261540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.